Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M30.3Revenue (TTM) $M--Net Margin (%)--Altman Z-Score-14.6
Enterprise Value $M21.2EPS (TTM) $-0.8Operating Margin %--Piotroski F-Score2
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book8.310-y EBITDA Growth Rate %-5.8Quick Ratio3.9Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %5.0Current Ratio3.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-102.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-191.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M29.4ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with GALT

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GALTGeorge Soros 2014-06-30 Sold Out -0.01%$10.23 - $14.81
($12.43)
$ 1.03-92%Sold Out0
GALTGeorge Soros 2014-03-31 Buy 0.01%$8.025 - $18.3
($14.02)
$ 1.03-93%New holding48,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GALT is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GALT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CZIRR JAMES CDirector 2016-04-20Sell44,312$1.67-38.32view
10X Fund, L.P.10% Owner 2016-04-20Sell44,312$1.67-38.32view
10X Fund, L.P.10% Owner 2016-04-20Sell44,312$1.65-37.58view
CZIRR JAMES CDirector 2016-04-20Sell44,312$1.65-37.58view
Greenberg ArthurDirector 2016-01-05Buy1,666$1.72-40.12view
AMELIO GILBERT FDirector 2015-11-30Sell100$2.1-50.95view
TRABER PETER GPresident & CEO 2015-08-12Buy2,000$2-48.5view
TRABER PETER GPresident & CEO 2015-06-01Buy4,000$2.53-59.29view
FREEMAN KEVIN DDirector 2015-06-01Buy2,083$2.7-61.85view
AMELIO GILBERT FDirector 2014-12-15Sell110$3.69-72.09view

Press Releases about GALT :

Quarterly/Annual Reports about GALT:

News about GALT:

Articles On GuruFocus.com
No related article found.

More From Other Websites
Galectin Therapeutics to Webcast Corporate Update At Annual Meeting of Stockholders Dec 08 2016
GALECTIN THERAPEUTICS INC Financials Nov 15 2016
Galectin Buoyed By Plaque Psoriasis Study (GALT) Nov 11 2016
Galectin Therapeutics Announces Positive New Psoriasis and Atopic Dermatitis Clinical Data, Seeking... Nov 10 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Nov 10 2016
Galectin Therapeutics Announces Positive New Psoriasis and Atopic Dermatitis Clinical Data, Seeking... Nov 10 2016
Galectin Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update Nov 08 2016
Galectin Therapeutics Reports Third Quarter 2016 Financial Results and Provides Business Update Nov 08 2016
GALECTIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 08 2016
GALECTIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Nov 08 2016
Research Reports Coverage on Generic Drugs Stocks -- Evoke Pharma, Catalyst Pharma, Neurocrine... Oct 31 2016
Galectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in... Oct 17 2016
Galectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in... Oct 17 2016
Galectin Therapeutics, Inc. to Present at The MicroCap Conference on October 24-25 in Philadelphia Oct 11 2016
Galectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development... Oct 07 2016
Galectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development... Oct 07 2016
Galectin Therapeutics downgraded by FBR & Co. Oct 03 2016
Galectin Tanks on Failure of NASH Treatment (GALT) Sep 29 2016
Galectin Therapeutics (GALT) Stock Declines on Drug Failure, Rating Cut Sep 28 2016
Why Traders Are Talking About Origin Agritech, Galectin, Avis, Hertz, and More Sep 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)